An NSF International Company

Industry news

NSF Health Sciences experts bring you the latest news updates from the industry

ICH Q7 Implementation Working Group

Wednesday the 5th December 2012

At their last meeting the ICH Steering Committee approved a Concept Paper that recommended the setting up of an Implementation Working Group (IWG) to produce a Q&A document for Q7, the GMPs for APIs.

The need for this IWG was based on experience gained with the implementation of the ICH Q7 Guideline since its finalisation in 2000, which shows that uncertainties related to the interpretation of some sections exist. Technical issues with regard to GMP of APIs – also in context with new ICH Guidelines (Q8, 9, 10 & 11) - will be addressed in this Question and Answer document in order to harmonize expectations during inspections, to remove ambiguities and uncertainties and also to harmonise the inspections of both small molecules and biotech APIs.

A copy of the Concept Paper is attached.

Quick links

NSF Health Sciences have offices in Kirkbymoorside and Sheffield, UK and Washington and Ann Arbor, USA

A word from NSF Health Sciences

The legislation and guidance that apply to the healthcare industries is forever changing. NSF Health Sciences will provide you with regular updates on what is new and will also provide you with expert interpretation of these changes - what they mean

Peter Gough

© NSF Health Sciences 2015

Registered Office: NSF Health Sciences, The Georgian House, 22/24 West End, Kirkbymoorside, York, UK, YO62 6AF
Registered in England and Wales No: 3432550 | Tel: +44(0)1751 432999 | Fax: +44(0)1751 432450 | Email: [email protected]
US Office: NSF Health Sciences, 2001 Pennsylvania Ave, NW, Suite 950, Washington DC 20006 | Tel: 1-202-822-1850 | Fax: 1-202-822-1859 | Email: [email protected]